ZNF561
Zinc finger protein 561
Also known as: MGC45408, ZN561_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N587
- Gene
- ZNF561
- Ensembl
- ENSG00000171469
- Chromosome
- 19
- Canonical length
- 486 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
486 residues, UniProt reviewed canonical sequence.
>Q8N587|ZNF561
1 MAAIYLSRGF FSREPICPFE EKTKVERMVE DYLASGYQDS VTFDDVAVDF TPEEWALLDT
61 TEKYLYRDVM LENYMNLASV EWEIQPRTKR SSLQQGFLKN QIFSGIQMTR GYSGWKLCDC
121 KNCGEVFREQ FCLKTHMRVQ NGGNTSEGNC YGKDTLSVHK EASTGQELSK FNPCGKVFTL
181 TPGLAVHLEV LNARQPYKCK ECGKGFKYFA SLDNHMGIHT DEKLCEFQEY GRAVTASSHL
241 KQCVAVHTGK KSKKTKKCGK SFTNFSQLYA PVKTHKGEKS FECKECGRSF RNSSCLNDHI
301 QIHTGIKPHK CTYCGKAFTR STQLTEHVRT HTGIKPYECK ECGQAFAQYS GLSIHIRSHS
361 GKKPYQCKEC GKAFTTSTSL IQHTRIHTGE KPYECVECGK TFITSSRRSK HLKTHSGEKP
421 FVCKICGKAF LYSSRLNVHL RTHTGEKPFV CKECGKAFAV SSRLSRHERI HTGEKPYECK
481 DMSVTILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF561 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- smooth muscle: 24 nTPM
- ovary: 18 nTPM
- urinary bladder: 18 nTPM
- fallopian tube: 18 nTPM
- endometrium: 17 nTPM
- seminal vesicle: 17 nTPM
Single-cell type
- esophageal apical cells: 119 nCPM
- esophageal suprabasal cells: 66 nCPM
- epididymal basal cells: 62 nCPM
- urothelial cells: 49 nCPM
- ocular epithelial cells: 43 nCPM
- breast myoepithelial cells: 38 nCPM
Immune cell
- MAIT T-cell: 6.2 nTPM
- eosinophil: 5.8 nTPM
- naive CD4 T-cell: 5.4 nTPM
- classical monocyte: 5.2 nTPM
- intermediate monocyte: 5.1 nTPM
- gdT-cell: 4.9 nTPM
Brain region
- cerebral cortex: 17 nTPM
- cerebellum: 16 nTPM
- medulla oblongata: 15 nTPM
- pons: 15 nTPM
- thalamus: 14 nTPM
- midbrain: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.25
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF561 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF561 as an antibody target. Whether an autoantibody or antibody against ZNF561 could matter depends on whether native ZNF561 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF561 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF561 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...